You are here
Dysregulation of Angiopoietin 1 and 2 in Escherichia coli O157:H7 Infection and the Hemolytic-Uremic Syndrome.
Title | Dysregulation of Angiopoietin 1 and 2 in Escherichia coli O157:H7 Infection and the Hemolytic-Uremic Syndrome. |
Publication Type | Journal Article |
Year of Publication | 2013 |
Authors | Page, AV, Tarr, PI, Watkins, SL, Rajwans, N, Petruzziello-Pellegrini, TN, Marsden, PA, Kain, KC, W Liles, C |
Journal | J Infect Dis |
Volume | 208 |
Issue | 6 |
Pagination | 929-33 |
Date Published | 2013 Sep |
ISSN | 1537-6613 |
Abstract | Escherichia coli O157:H7-associated hemolytic-uremic syndrome (HUS) is characterized by profound prothrombotic abnormalities. Endothelial dysfunction, manifested as dysregulation of angiopoietins 1 and 2 (Ang-1/2), could underlie HUS pathophysiology. We measured Ang-1/2 in 77 children with E. coli O157:H7 infection. Ang-1, Ang-2, and the Ang-2/Ang-1 ratio were significantly different in HUS vs the pre-HUS phase of illness or uncomplicated infection. Angiopoietin dysregulation preceded HUS and worsened as HUS developed. In vitro exposure of human microvascular endothelial cells to Shiga toxin recapitulated the in vivo observations. Angiopoietin regulation is profoundly affected before and during HUS, reflecting that subclinical endothelial dysfunction precedes overt microangiopathy. |
DOI | 10.1093/infdis/jit268 |
Alternate Journal | J. Infect. Dis. |
PubMed ID | 23801605 |